What Effective Early Lifecycle Management Enables
Create a Lifecycle Pathway Where Value Compounds
To realize the full potential of your asset, your lifecycle plan must work together as a coordinated system rather than a collection of disconnected activities.
Align not only supports the identification and prioritization of lifecycle opportunities, but helps orchestrate them into a cohesive plan that works in concert. We guide indication and beyond-indication initiatives across the lifecycle so each decision reinforces the next, creating value that compounds over time rather than pursuing isolated opportunities with limited strategic impact.
Maintain an Agile and Adaptable Lifecycle Plan
No drug’s lifecycle unfolds exactly as planned. The most effective organizations recognize that early lifecycle planning is not a one-time exercise, but rather requires a living, breathing approach.
Align supports your planning by building in optionality from the start. Your preferred directions is backed up with alternate pathways, clear decision points, and contingency plans, so teams can adapt confidently as competitive dynamics, clinical evidence, and organizational priorities evolve.
Align Teams Around a Shared Asset Vision
Lifecycle management is inherently a cross-functional process. A wide range of teams all influence the future direction of an asset – but they often find themselves working in isolation each with their own view of what’s best for the asset.
We help organizations to establish a shared strategic vision that aligns decision-making across functions. By creating a common understanding of lifecycle priorities and long-term objectives, teams can ensure their efforts reinforce one another and support a coherent path to value creation.
How We Support Early Lifecycle Management
Why Align Strategy?
-
Full Lifecycle Perspective
From early development to loss of exclusivity and beyond, our end-to-end lifecycle expertise gives us a clear understanding of the long-term consequences of today’s decisions and investments.
-
Alignment Specialists
We are skilled at bringing different perspectives together. Through structured frameworks and facilitation, we help teams get the necessary buy-in, shared strategic vision, and alignment around their priorities.
-
Built for Uncertainty
We build optionality into your early lifecycle planning, so you remain agile even as evidence, competition, and global markets evolve.
-
Proven LCM Frameworks
Leverage our proprietary early LCM frameworks to move beyond abstract discussions and start making smart, aligned decisions that are grounded in a common strategic language.
A Closer Look at Our Early LCM Programs
Early Lifecycle Offering
Objective
Our Solution
Objective
Explore the Full Universe of Lifecycle Opportunities
Leave no stone unturned as you set the trajectory for the entire asset, ensuring that early development choices reinforce, rather than constrain, long-term lifecycle ambitions.
Our Solution
Indication Priortization and Sequencing
Look beyond feasibility and speed to design the strategic entry point to your lifecycle pathway and choose an order and pace of indication expansion that compounds clinical, commercial, and strategic advantage.
Beyond-Indication Tactic Prioritization and Sequencing
Apply a structured lens to identify, prioritize, and effectively sequence beyond-indication opportunities (i.e., product and solution optimization) that reinforce the asset’s defined lifecycle pathway and long-term value potential.
Objective
A Coordinated Lifecycle Strategy
Develop a pressure-tested early lifecycle management strategy, tied to a long-term vision, with clear visibility into trade-offs, risks, and dependencies, enabling more confident investment decisions and avoiding reactive lifecycle approaches.
Our Solution
Development and Validation
Transform individual lifecycle initiatives into a cohesive plan grounded in a shared strategic lens and designed to work as an integrated system that amplifies value rather than just filling a checklist.
Pressure-test
Support internal pressure-tests by reviewing existing plans and materials, gathering perspectives involved in planning, and facilitating a cross-functional workshop, helping you bring alignment while identifying any weaknesses and opportunities.
Health Check
An Align Strategy-led review of existing plans and materials followed by development of a comprehensive report providing targeted recommendations for early LCM plan optimization and proposed next steps for your team to initiate.
Objective
Create a Shared Foundation for Better Lifecycle Decision-making
Align teams around a common early lifecycle vision and create shared accountability for decision-making, enabling a consistent, repeatable application of early lifecycle thinking.
Our Solution
Embedding the Discipline
Embed early lifecycle management as a leadership-endorsed organizational discipline. Establish a shared strategic language, defined templates, frameworks, processes, and governance to support early lifecycle decision-making across assets.
Expert Training Sessions
Customized training programs that equip teams with a deep understanding of the processes behind early lifecycle strategy, supported by our proprietary frameworks.
Webinar: Unlocking Durable Asset Value
In this on-demand webinar, Dr. Neal Hansen shares sharp insights on how early lifecycle management can dramatically impact a product’s long-term value – and what effective planning should look like. Discover how a strong lifecycle management plan empowers you to maximize early-stage assets and what’s at stake if you don’t have one in place.
Key Expertise In Early Lifecycle Strategy
We bring decades of experience shaping early lifecycle strategy, with deep expertise in driving long-term asset growth.
AlignOn Early Lifecycle Management Insights
Lifecycle Management
Early Lifecycle Management: Your Compass for Unlocking Asset Value
Developing a new pharmaceutical asset is not unlike the voyage of cargo ship: success depends on having a compass to guide you. In pharma, that compass is early lifecycle management planning.
Lifecycle Management
Going Beyond Indication Expansion: A Framework for Rethinking Lifecycle Management
Introducing a lifecycle management framework to help pharmaceutical teams go beyond indication expansion by considering the breadth, depth, and sustainability of an asset.
Lifecycle Management
How to Analyse Unmet Needs to Drive Opportunity
Capture and build on unmet needs during indication prioritisation. Avoid oversimplification to seize true opportunities for developmental assets.
